GRASSI, SUSANNA
 Distribuzione geografica
Continente #
NA - Nord America 2.102
AS - Asia 1.110
EU - Europa 951
SA - Sud America 144
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.381
Nazione #
US - Stati Uniti d'America 2.045
CN - Cina 393
SG - Singapore 356
IT - Italia 258
SE - Svezia 227
HK - Hong Kong 133
DE - Germania 121
BR - Brasile 115
GB - Regno Unito 109
VN - Vietnam 78
BG - Bulgaria 67
FR - Francia 50
CA - Canada 42
FI - Finlandia 40
IN - India 35
TR - Turchia 34
CI - Costa d'Avorio 33
JP - Giappone 28
RU - Federazione Russa 22
BE - Belgio 11
PL - Polonia 8
UZ - Uzbekistan 8
ES - Italia 7
NG - Nigeria 7
NL - Olanda 7
UA - Ucraina 7
VE - Venezuela 7
ZA - Sudafrica 7
AR - Argentina 6
LT - Lituania 6
SA - Arabia Saudita 6
SN - Senegal 6
IQ - Iraq 5
MY - Malesia 5
BD - Bangladesh 4
EC - Ecuador 4
KE - Kenya 4
CL - Cile 3
CZ - Repubblica Ceca 3
GR - Grecia 3
IL - Israele 3
KR - Corea 3
KZ - Kazakistan 3
MA - Marocco 3
MX - Messico 3
PH - Filippine 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CO - Colombia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
ID - Indonesia 2
JO - Giordania 2
PR - Porto Rico 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
BJ - Benin 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
IR - Iran 1
LY - Libia 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SR - Suriname 1
SV - El Salvador 1
TG - Togo 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 4.381
Città #
Ashburn 233
Singapore 179
San Jose 152
Chandler 143
Fairfield 142
Woodbridge 142
Santa Clara 137
Hong Kong 127
Beijing 108
Houston 100
Serra 96
Dallas 94
Ann Arbor 91
Boardman 65
Seattle 65
Shanghai 65
Sofia 64
New York 57
Wilmington 49
Cambridge 45
Los Angeles 43
Munich 42
Princeton 42
Abidjan 33
London 33
Ottawa 30
Florence 27
Council Bluffs 26
Lawrence 26
Tokyo 25
Lauterbourg 24
Medford 24
Ho Chi Minh City 20
Bremen 18
Des Moines 17
Izmir 17
Milan 16
Helsinki 15
Pisa 14
Redondo Beach 14
Brussels 11
Fuzhou 11
São Paulo 11
Turku 11
Dearborn 10
Frankfurt am Main 10
Istanbul 10
Nanjing 10
Phoenix 9
San Diego 9
Alessandria 8
Changsha 8
Dong Ket 8
Duncan 8
Tashkent 8
Campinas 7
Hanoi 7
Hyderabad 7
Nuremberg 7
Redwood City 7
Warsaw 7
Dakar 6
Düsseldorf 6
Hefei 6
Lagos 6
New Delhi 6
Rio de Janeiro 6
Rome 6
Chennai 5
Denver 5
Falkenstein 5
Jiaxing 5
Johannesburg 5
Orem 5
Quanzhou 5
Shenyang 5
Boulder 4
Buffalo 4
Cascina 4
Chicago 4
Hangzhou 4
Hebei 4
Livorno 4
Nairobi 4
Stockholm 4
Toronto 4
Zhengzhou 4
Atlanta 3
Brooklyn 3
Chiavari 3
Delhi 3
Guangzhou 3
Guayaquil 3
Haiphong 3
Kent 3
Lancaster 3
Montreal 3
Nanchang 3
Olomouc 3
Palermo 3
Totale 3.009
Nome #
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia 248
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 217
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 212
The combination of rituximab and bendamustine as first-line treatment is highly effective in the eradicating minimal residual disease in follicular lymphoma: An Italian retrospective study 197
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia 191
TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME 185
Predictive role of WT1 and RPS14 expression in patients affected by myelodysplastic syndromes receiving azacitidine 184
MDS: An Integrated Workup for a Correct Diagnosis 182
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 181
Droplet digital PCR represents a new sensitive method for detecting B-RAFV600E mutation at diagnosis and during the follow-up of patients affected by hairy cell leukemia 178
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup 176
LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON-5Q-MYELODYSPLASTIC SYNDROMES 168
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice 162
Donor-transmitted Triple-Hit Lymphoma in a Renal Allograft Recipient 161
Altered Expression of Jak-Stat Pathway as Possible Predictive Marker in Patients Affected by Chronic Myeloid Leukemia Receiving Tyrosin Kinase Inhibitors (TKIS) 157
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients 156
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation 149
TYROSINE KINASE INHIBITORS SIGNIFICANTLY CHANGE THE EXPRESSION OF POLYCOMB GENES IN CHRONIC MYELOID LEUKEMIA 148
WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes 147
Low RPS14 expression negatively conditions the prognosis of patients affected by not 5q- myelodysplastic syndromes during azacitidine treatment 147
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EOSINOPHILOIA IN EGPA FROM HES 145
R-IPSS, RPS14 AND WT1 LEVELS ARE THE BEST PROGNOSTIC FACTORS FOR PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE TREATMENT. 141
Conventional Cytogenetics, ACGH, and PCR as Integrated Workup for a Correct Diagnosis of MDS 141
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network 136
THE C.480C>G POLYMORPHISM OF HOCT1 TRANSPORTER INFLUENCES IMATINIB CLEARANCE IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA 125
Myelodysplastic Syndromes: A Multidisciplinary Integrated Diagnostic Work-up for Patients' Risk Stratification 124
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma 103
Totale 4.461
Categoria #
all - tutte 13.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 0 0 0 0 34 38
2021/2022356 17 10 2 13 53 45 13 8 47 19 31 98
2022/2023524 86 107 32 49 43 43 5 47 76 6 29 1
2023/2024297 14 22 41 12 34 43 17 9 1 18 34 52
2024/2025956 1 30 6 61 102 97 102 51 96 115 96 199
2025/20261.108 78 108 106 116 132 100 182 69 70 133 14 0
Totale 4.461